Clinical Trials on Crigler Najjar Syndrome, Type 1 in Luxembourg
Total 13 results
-
Centre Hospitalier du LuxembourgUniversity of Cambridge; Luxembourg Institute of HealthCompletedType1 Diabetes MellitusLuxembourg
-
Centre Hospitalier du LuxembourgUniversity of CambridgeCompletedType 1 Diabetes MellitusLuxembourg
-
Luxembourg Institute of HealthCompletedDiabetes Distress | type1diabetesLuxembourg
-
Centre Hospitalier du LuxembourgCompletedDiabetes Mellitus, Type 1Luxembourg
-
University of CambridgeMedical University of Graz; Medical University of Vienna; The Leeds Teaching... and other collaboratorsCompletedType 1 Diabetes MellitusUnited Kingdom, Austria, Germany, Luxembourg
-
University of CambridgeMedical University of Graz; Medical University of Vienna; The Leeds Teaching... and other collaboratorsCompletedType 1 Diabetes MellitusUnited Kingdom, Austria, Germany, Luxembourg
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1France, Belgium, Luxembourg
-
University of CambridgeJuvenile Diabetes Research Foundation; The Leona M. and Harry B. Helmsley Charitable... and other collaboratorsUnknownType 1 Diabetes MellitusAustria, Italy, Finland, Denmark, Germany, Belgium, United Kingdom, France, Luxembourg, Norway, Poland, Slovenia, Sweden
-
Medtronic DiabetesCompletedDiabetes Mellitus, Type 1Netherlands, Slovenia, Denmark, Austria, Italy, Luxembourg, Spain
-
University of HelsinkiEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedDiabetes Mellitus, Type 1Spain, Luxembourg, Australia, Switzerland, Canada, Germany, Hungary, United States, Czechia, Estonia, Finland, Italy, Netherlands, Poland, Sweden
-
Stichting Hemato-Oncologie voor Volwassenen NederlandDeutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)RecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2Australia, Austria, Belgium, Estonia, Finland, France, Germany, Ireland, Lithuania, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland
-
Stichting Hemato-Oncologie voor Volwassenen NederlandAstellas Pharma Global Development, Inc.; Deutsch-Österreichische Studiengruppe...Active, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2Netherlands, Belgium, Germany, Switzerland, Australia, Finland, Norway, Sweden, Austria, France, Ireland, Lithuania, Luxembourg, Spain
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 1United Kingdom, Denmark, Sweden, Netherlands, Belgium, Finland, France, Australia, Ireland, Norway